However, exogenous CXCL16 and CM effectively promoted the in vitro invasiveness of lung cancer cell lines, and the induced invasive ability could be obviously blocked by CXCL16 neutralizing antibody or CXCR6 gene down-regulation. This evidence concerns the gene CXCR6 and lung carcinoma.